3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
75
Neoplasm Metastasis
12
Neoplasms
8
Ovarian Neoplasms
6
Endometrial Neoplasms
6
Pancreatic Neoplasms
5
Carcinoma, Renal Cell
5
Sarcoma
4
Neoplasms by Site
4
Lymphoma, Non-Hodgkin
4
Breast Diseases
4
Squamous Cell Carcinoma of Head and Neck
3
Multiple Myeloma
3
Lymphoma
3
Lung Neoplasms
3
Liposarcoma
3
Kidney Neoplasms
3
Head and Neck Neoplasms
3
Glioma
3
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Interventions
Paclitaxel
4
Cyclophosphamide
4
exemestane
3
Taxes
3
Tamoxifen
3
Letrozole
3
Doxorubicin
3
Anastrozole
3
Trastuzumab
2
Leuprolide
2
Immunotherapy
2
Goserelin
2
Carboplatin
2
trastuzumab biosimilar HLX02
1
ribociclib
1
pegfilgrastim
1
elacestrant
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abemaciclib
1
Vitamins
1
Standard of Care
1
Radiosurgery
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
PF-05280014
1
Ontruzant
1
Omeprazole
1
Ogivri
1
Neoadjuvant Therapy
1
Methods
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
palbociclib
×
1 year
×
Clear all
No trials found.